| abstract |
The present disclosure is a tyrosine kinase, particularly a BTK inhibitor, and a compound of formula (IA) potentially useful for the treatment of diseases treatable by inhibition of tyrosine kinase (e.g., inflammatory diseases such as cancer, arthritis, etc.) and/or pharmaceuticals thereof It discloses an acceptable salt. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof, and methods of preparing such compounds and pharmaceutically acceptable salts thereof. |